ClinicalTrials.gg
CompletedNCT02344615Updated Jan 28, 2016

Nerve Stimulator Versus Ultrasound-guided Infraclavicular Block

An interventional study of NS-guided infraclavicular block and US-guided infraclavicular block in Pain, sponsored by Cheju Halla General Hospital. Completed at 1 site in South Korea. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2016-01-28.

Sponsored by Cheju Halla General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The investigators compared the postoperative analgesia of nerve stimulator-guided and ultrasound-guided infraclavicular block for upper extremity surgery.

Read the detailed description

Ultrasound (US)-guided peripheral nerve block has increased in popularity. It has many advantages such as improved success rate, faster onset time, fewer needle passes, shorter performance time, and reduced procedural pain and vascular puncture. However, there is no information about postoperative analgesia.

Therefore, the investigators tested whether ultrasound-guided peripheral nerve block enhanced the postoperative analgesia for upper extremity surgery compared with nerve stimulator (NS) guidance.

02

Conditions studied

  • Pain

Browse trials for

Keywords

  • nerve stimulator
  • ultrasound
03

In context

Pain

2,450 studies on the registry are indexed under Pain; 945 are open to participants now.

This study's planned enrollment of 44 is below the median of 70 across 2,101 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Cheju Halla General Hospital is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • American Society of Anesthesiologists physical class I - III patients scheduled to undergo upper extremity surgery

Exclusion criteria

Exclusion Criteria:

  • coagulopathy, severe pulmonary disease, neuropathy, contralateral diaphragmatic paresis, allergy to study medications
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Active comparator
    NS-guided infraclavicular block

    NS-guided infraclavicular block is performed using 35 ml of 0.5% ropivacaine.

    Procedure: NS-guided infraclavicular block

  • Experimental
    US-guided infraclavicular block

    US-guided infraclavicular block is performed using 35 ml of 0.5% ropivacaine.

    Procedure: US-guided infraclavicular block

Interventions

  • ProcedureNS-guided infraclavicular block

    Patients received a standard single injection infraclavicular block using the lateral sagittal approach of Klaastad. The infraclavicular brachial plexus is identified using an insulated needle connected to a nerve stimulator. Placement of the needle is considered adequate if motor response of radial nerve in the hand or wrist is still present at 0.2 - 0.5mA. Ropivacaine 0.5% 35ml is used.

  • ProcedureUS-guided infraclavicular block

    Infraclavicular block is performed under ultrasound guidance. Linear probe is placed in a parasagittal positon below the clavicle medial to the coracoid process and adjusted to achieve a cross-sectional image of the axillary artery. Using in-plane technique, an 22-gauge insulated needle is advanced caudally and posteriorly to the axillary artery. Subsequently, 35 ml of 0.5% ropivacaine is incrementally injected.

06

What researchers measure

Primary outcomes

  1. Duration of postoperative analgesia

    time from completion of local anesthetic injection until the first request for an analgesic

    Time frame: at 24h after surgery

Secondary outcomes

  1. block performance time

    the time between the block needle insertion and needle withdrawal

    Time frame: at 30 min after block placement

  2. number of needle redirections

    either forward or backward movement of needle at least 1 cm or more

    Time frame: at 30 min after block placement

  3. patient discomfort

    pain score (0-10) during the procedure

    Time frame: at 30 min after block placement

  4. paresthesia

    presence of paresthesia during the procedure

    Time frame: at 30 min after block placement

  5. onset time

    complete block of sensory nerve (radial, ulnar, median, musculocutaneous, and medial antebrachial cutaneous nerve)

    Time frame: until 30min after completion of local anesthetic

  6. motor block of hand

    presence of motor block in the operated hand

    Time frame: at 24h after surgery

  7. postoperative dysesthesia

    presence of any paresthesia in the operated extremity

    Time frame: at 24h after surgery

  8. supplemental analgesia

    Rescue analgesia with 75 mg of IM diclofenac was available on demand.

    Time frame: at 24h after surgery

  9. Pain score

    Time frame: at 24h after surgery

  10. Patient satisfaction

    The acceptance of the anesthetic technique was evaluated using a two-point score: 1, satisfactory (if necessary, I would have the same anesthetic technique); and 2, unsatisfactory (different anesthetic technique).

    Time frame: at 24h after surgery

07

Study locations

1 site
  • Cheju Halla General Hopsital
    Jeju City, Jeju Self-governing Province 670-744, South Korea
08

References and documents

Publications

  • Choi S, McCartney CJ. Evidence Base for the Use of Ultrasound for Upper Extremity Blocks: 2014 Update. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):242-50. doi: 10.1097/AAP.0000000000000155. PubMed 25376973 ↗
  • Koscielniak-Nielsen ZJ. Ultrasound-guided peripheral nerve blocks: what are the benefits? Acta Anaesthesiol Scand. 2008 Jul;52(6):727-37. doi: 10.1111/j.1399-6576.2008.01666.x. Epub 2008 May 12. PubMed 18477070 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 28, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02344615
Lead sponsor
Cheju Halla General Hospital
Responsible party
Chunwoo Yang (Department of Anesthesiology and pain medicine, Cheju Halla General Hospital) — Principal investigator
First posted
Jan 26, 2015
Start date
May 2014
Primary completion
Dec 2015
Completion
Dec 2015
Last update
Jan 28, 2016

Study contacts

Chunwoo Yang, MD
principal investigator · Dept. of anesthesia and pain medicine, Cheju Halla General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion